Publication | Closed Access

HDAC1/MAO-B dual inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid/o-aminobenzamide hybrids

Molecular PharmacologyMedicinal ChemistryNeurodegenerative DiseasesAlzheimer's DiseaseBiochemistryMedicineN-propargylamine-hydroxamic Acid/o-aminobenzamide HybridsNatural SciencesRational Drug DesignPharmacological AgentPharmacotherapyBiological EvaluationDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug DiscoveryHdac1/mao-b Dual Inhibitors